Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-12-27 Sale |
2023-12-29 8:30 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,414 | $24 | $129,936 | 288,195 (Indirect Direct) |
View |
| 2023-12-14 Sale |
2023-12-18 8:49 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
597 | $20.76 | $12,394 | 77,910 (Direct) |
View |
| 2023-12-14 Sale |
2023-12-18 8:40 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
611 | $20.76 | $12,684 | 50,354 (Direct) |
View |
| 2023-12-14 Sale |
2023-12-18 8:39 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
543 | $20.76 | $11,273 | 245,131 (Indirect Direct) |
View |
| 2023-12-14 Sale |
2023-12-18 8:37 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
1,628 | $20.76 | $33,797 | 550,911 (Direct) |
View |
| 2023-12-14 Sale |
2023-12-18 8:29 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
514 | $20.76 | $10,671 | 182,672 (Direct) |
View |
| 2023-12-08 Purchase |
2023-12-11 9:06 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
100,000 | $19.83 | $1,982,940 | 802,168 (Indirect Direct) |
View |
| 2023-12-07 Sale |
2023-12-11 8:59 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
26,978 | $20.02 | $539,969 | 1,031,224 (Direct) |
View |
| 2023-11-30 Purchase |
2023-12-05 08:37 am |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
100,000 | $16.95 | $1,694,565 | 702,168 (Indirect Direct) |
View |
| 2023-11-17 Sale |
2023-11-21 5:30 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
30,000 | $14.68 | $440,259 | 213,177 (Indirect Direct) |
View |
| 2023-10-02 Sale |
2023-10-04 8:41 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $47.91 | $1,197,827 | 500,998 (Direct) |
View |
| 2023-10-02 Sale |
2023-10-04 8:33 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
490 | $51.1 | $25,039 | 329,908 (Indirect Direct) |
View |
| 2023-09-13 Sale |
2023-09-25 8:36 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
1,682 | $50.34 | $84,672 | 460,998 (Direct) |
View |
| 2023-09-13 Sale |
2023-09-25 8:31 pm |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
632 | $50.34 | $31,815 | 18,468 (Direct) |
View |
| 2023-09-13 Sale |
2023-09-25 8:31 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,617 | $48.32 | $271,416 | 71,182 (Direct) |
View |
| 2023-09-13 Sale |
2023-09-25 8:30 pm |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
531 | $50.34 | $26,731 | 150,689 (Direct) |
View |
| 2023-09-13 Sale |
2023-09-25 8:28 pm |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
562 | $50.34 | $28,291 | 243,177 (Indirect Direct) |
View |
| 2023-09-01 Sale |
2023-09-18 6:48 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $49.77 | $1,244,248 | 527,680 (Direct) |
View |
| 2023-08-28 Sale |
2023-08-30 7:04 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,745 | $49.99 | $287,191 | 76,799 (Direct) |
View |
| 2023-08-08 Purchase |
2023-08-10 4:46 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
25,000 | $42.06 | $1,051,475 | 602,168 (Indirect Direct) |
View |
| 2023-08-01 Sale |
2023-08-03 4:13 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $43.15 | $1,078,867 | 537,680 (Direct) |
View |
| 2023-07-28 Purchase |
2023-08-01 7:52 pm |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
55,000 | $42.95 | $2,362,234 | 577,168 (Indirect Direct) |
View |
| 2023-07-03 Sale |
2023-07-06 8:44 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $44.88 | $1,122,041 | 562,680 (Direct) |
View |
| 2023-06-21 Sale |
2023-06-23 8:06 pm |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
33,349 | $51.74 | $1,725,390 | 46,627 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-02 Exercise |
2024-01-03 5:00 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
40,000 | $0 | 615,449 (Direct) |
View |
| 2024-01-02 Exercise |
2024-01-03 5:00 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
40,000 | $0.615 | 615,449 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 8:30 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,414 | $6.36 | 288,195 (Direct) |
View |
| 2023-12-27 Exercise |
2023-12-29 8:30 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
5,414 | $0 | 288,195 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-12 4:43 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
178,734 | $0 | 197,202 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-12 4:43 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
178,734 | $0 | 391,911 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-12 4:38 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer |
178,734 | $0 | 329,423 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-12 4:35 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Lamy Patrick See Remarks |
102,134 | $0 | 102,134 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-12 4:26 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
178,734 | $0 | 224,744 (Direct) |
View |
| 2023-12-08 Option Award |
2023-12-11 8:59 pm |
N/A 2033-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
503,477 | $0 | 1,031,224 (Direct) |
View |
| 2023-12-07 Exercise |
2023-12-11 8:59 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
26,978 | $6.36 | 1,031,224 (Direct) |
View |
| 2023-12-07 Exercise |
2023-12-11 8:59 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
26,978 | $0 | 1,031,224 (Direct) |
View |
| 2023-11-09 Option Award |
2023-11-13 5:37 pm |
N/A 2033-11-08 |
Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer |
83,400 | $0 | 83,400 (Direct) |
View |
| 2023-10-02 Exercise |
2023-10-04 8:41 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $6.36 | 500,998 (Direct) |
View |
| 2023-10-02 Exercise |
2023-10-04 8:41 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $0 | 500,998 (Direct) |
View |
| 2023-10-02 Exercise |
2023-10-04 8:33 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
490 | $21.1 | 329,908 (Direct) |
View |
| 2023-10-02 Exercise |
2023-10-04 8:33 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer |
490 | $0 | 329,908 (Direct) |
View |
| 2023-09-21 Exercise |
2023-09-25 8:31 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,000 | $6.36 | 71,182 (Direct) |
View |
| 2023-09-21 Exercise |
2023-09-25 8:31 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,000 | $0 | 71,182 (Direct) |
View |
| 2023-09-01 Exercise |
2023-09-18 6:48 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $6.36 | 527,680 (Direct) |
View |
| 2023-09-01 Exercise |
2023-09-18 6:48 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $0 | 527,680 (Direct) |
View |
| 2023-08-30 Exercise |
2023-08-30 7:04 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
15,000 | $0 | 564,892 (Direct) |
View |
| 2023-08-30 Exercise |
2023-08-30 7:04 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
15,000 | $0.615 | 564,892 (Direct) |
View |
| 2023-08-28 Exercise |
2023-08-30 7:04 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,745 | $6.36 | 76,799 (Direct) |
View |
| 2023-08-28 Exercise |
2023-08-30 7:04 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer |
5,745 | $0 | 76,799 (Direct) |
View |
| 2023-08-01 Exercise |
2023-08-03 4:13 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $6.36 | 537,680 (Direct) |
View |
| 2023-08-01 Exercise |
2023-08-03 4:13 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $0 | 537,680 (Direct) |
View |
| 2023-07-03 Exercise |
2023-07-06 8:44 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $6.36 | 562,680 (Direct) |
View |
| 2023-07-03 Exercise |
2023-07-06 8:44 pm |
N/A 2029-01-15 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
25,000 | $0 | 562,680 (Direct) |
View |
| 2023-06-27 Exercise |
2023-06-27 7:12 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
40,000 | $0 | 564,892 (Direct) |
View |
| 2023-06-27 Exercise |
2023-06-27 7:12 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
40,000 | $0.615 | 564,892 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 6:00 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Xu Yuan Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:58 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Judy Chou Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:55 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Henderson Jane Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:52 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:48 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:48 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-06-23 Option Award |
2023-06-27 5:39 pm |
N/A 2033-06-22 |
Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director |
15,000 | $0 | 15,000 (Direct) |
View |